Additionally, the discrepancy between our results and other findings reflects a cell type-specific mode of hypoxic p62 regulation; therefore, the careful consideration of tumor types is required when developing strategies for solid tumor therapies targeting these pathways. This evidence concerns the gene SQSTM1 and neoplasm.